Copy number variation in the CES1 gene and the risk of non-alcoholic fatty liver in a Chinese Han population

Bing bing Chen,Jian hui Yan,Jing Zheng,He wei Peng,Xiao ling Cai,Xin ting Pan,Hui quan Li,Qi zhu Hong,Xian-E Peng

DOI: https://doi.org/10.1038/s41598-021-93549-2

IF: 4.6

2021-07-07

Scientific Reports

Abstract:Abstract A recent genome-wide copy number variations (CNVs) scan identified a 16q12.2 deletion that included the carboxylesterase 1 ( CES1 ) gene, which is important in the metabolism of fatty acids and cholesterol. We aimed to investigate whether CES1 CNVs was associated with susceptibility to non-alcoholic fatty liver disease (NAFLD) in a Chinese Han population. A case–control study was conducted among 303 patients diagnosed with NAFLD and 303 age (± 5) and sex-matched controls from the Affiliated Nanping First Hospital of Fujian Medical University in China . The copy numbers of CES1 were measured using TaqMan quantitative real-time polymerase chain reaction (qPCR) and serum CES1 was measured using enzyme-linked immunosorbent assays. The Chi-squared test and a logistic regression model were used to evaluate the association between CES1 CNVs and NAFLD susceptibility. The distribution of CES1 CNVs showed a higher frequency of CNVs loss (< 2) among patients; however, the difference was not significant ( P = 0.05). After controlling for other known or suspected risk factors for NAFLD, CES1 CNVs loss was significantly associated with greater risk of NAFLD (adjusted OR = 2.75, 95% CI 1.30–5.85, P = 0.01); while CES1 CNVs gain (> 2) was not. There was a suggestion of an association between increased CES1 serum protein levels and CNVs losses among cases, although this was not statistically significant ( P = 0.07). Copy number losses (< 2) of CES1 contribute to susceptibility to NAFLD in the Chinese Han population.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper attempts to explore the relationship between CES1 gene copy number variations (CNVs) and non - alcoholic fatty liver disease (NAFLD) susceptibility, especially in the Chinese Han population. Through a case - control study, the researchers aimed to verify whether the reduction in the copy number of the CES1 gene is associated with an increased risk of NAFLD. The study found that a reduction in the CES1 gene copy number (< 2 copies) significantly increased the risk of developing NAFLD (adjusted OR value = 2.75, 95% CI 1.30 - 5.85, P = 0.01), while an increase in the copy number (> 2 copies) did not show a significant association. In addition, the study also preliminarily observed that a reduction in the CES1 gene copy number may be related to an increase in the CES1 protein level in serum, although this result was not statistically significant (P = 0.07). These findings provide a new perspective for understanding the potential role of CES1 in the development of NAFLD and emphasize the need for further research, especially verification studies in different populations.